Quick Answer
Core Laboratories Inc. /DE/ reported Total Revenue of $526.52 million for fiscal year 2025.
Core Laboratories Inc. /DE/ — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $526.52M +0.5% |
$523.85M +2.8% |
$509.79M +4.1% |
$489.74M +4.1% |
$470.25M | — |
| Revenue (ASC 606) | $526.52M +0.5% |
$523.85M +2.8% |
$509.79M +4.1% |
$489.74M +4.1% |
$470.25M | — |
| Net Income | $29.67M -5.5% |
$31.40M -14.4% |
$36.67M +88.5% |
$19.45M -1.4% |
$19.73M | — |
| Diluted EPS | $0.63 -4.5% |
$0.66 -14.3% |
$0.77 +83.3% |
$0.42 +0.0% |
$0.42 | — |
| Total Assets | $584.01M -0.2% |
$585.13M -0.2% |
$586.39M +1.4% |
$578.35M -0.4% |
$580.85M | — |
| Cash and Equivalents | $22.70M +18.5% |
$19.16M +26.7% |
$15.12M -2.0% |
$15.43M | — | — |
| Stockholders Equity | $265.99M +7.9% |
$246.57M +9.7% |
$224.81M +22.0% |
$184.26M +14.4% |
$161.00M +113.0% |
$75.57M |
| Operating Income | $56.47M -3.6% |
$58.56M +7.2% |
$54.64M +31.6% |
$41.52M -8.3% |
$45.26M | — |
| Shares Outstanding | 46.10M -1.6% |
46.83M -0.1% |
46.86M +0.5% |
46.63M | — | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $134.52M | +0.1% | +3.4% |
| Revenue (ASC 606) | September 30, 2025 | $134.52M | +0.1% | +3.4% |
| Net Income | September 30, 2025 | $14.24M | +21.2% | +33.9% |
| Diluted EPS | September 30, 2025 | $0.30 | +20.0% | +36.4% |
| Total Assets | September 30, 2025 | $591.36M | -1.5% | -1.8% |
| Cash and Equivalents | September 30, 2025 | $25.63M | +19.3% | -17.8% |
| Stockholders Equity | September 30, 2025 | $271.35M | +8.2% | +3.9% |
| Operating Income | September 30, 2025 | $20.93M | +5.7% | +36.9% |
| Shares Outstanding | September 30, 2025 | 46.09M | -1.8% | -1.0% |
- Core Laboratories Inc. /DE/ reported Total Revenue of $526.52 million for fiscal year 2025.
- Core Laboratories Inc. /DE/ showed an increase of +0.5% in Total Revenue compared to the prior fiscal year.
- Core Laboratories Inc. /DE/ reported Revenue (ASC 606) of $526.52 million for fiscal year 2025.
- Core Laboratories Inc. /DE/ showed an increase of +0.5% in Revenue (ASC 606) compared to the prior fiscal year.
- Core Laboratories Inc. /DE/ reported Net Income of $29.67 million for fiscal year 2025.
- Core Laboratories Inc. /DE/ showed a decrease of -5.5% in Net Income compared to the prior fiscal year.
- Core Laboratories Inc. /DE/ reported Diluted EPS of $0.63 per share for fiscal year 2025.
- Core Laboratories Inc. /DE/ showed a decrease of -4.5% in Diluted EPS compared to the prior fiscal year.
- Core Laboratories Inc. /DE/ reported Total Assets of $584.01 million for fiscal year 2025.
- Core Laboratories Inc. /DE/ showed a decrease of -0.2% in Total Assets compared to the prior fiscal year.
- Core Laboratories Inc. /DE/ reported Cash and Equivalents of $22.70 million for fiscal year 2025.
- Core Laboratories Inc. /DE/ showed an increase of +18.5% in Cash and Equivalents compared to the prior fiscal year.
- Core Laboratories Inc. /DE/ reported Stockholders Equity of $265.99 million for fiscal year 2025.
- Core Laboratories Inc. /DE/ showed an increase of +7.9% in Stockholders Equity compared to the prior fiscal year.
- Core Laboratories Inc. /DE/ reported Operating Income of $56.47 million for fiscal year 2025.
- Core Laboratories Inc. /DE/ showed a decrease of -3.6% in Operating Income compared to the prior fiscal year.
- Core Laboratories Inc. /DE/ reported Shares Outstanding of 46.10 million shares for fiscal year 2025.
- Core Laboratories Inc. /DE/ showed a decrease of -1.6% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: